From 2016 but still good overview. I'm headed to AMP Annual Conference to discuss these issues and others re economics and reimbursement. The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer https
RT @collabrx: Read AMP's list of justifications for molecular testing of #cancer #PrecisionMedicine #healthcare #patients https://t.co/5RSE…
RT @collabrx: Read AMP's list of justifications for molecular testing of #cancer #PrecisionMedicine #healthcare #patients https://t.co/5RSE…
Find the article here: https://t.co/S57b3zo4h7. FREE to all readers! https://t.co/akx5VA9Iq5
RT @Genomeducator: Horray!! A broader definition of clinical utility from @ampath. A must read!! https://t.co/uwke0zG6yH
RT @Genomeducator: Horray!! A broader definition of clinical utility from @ampath. A must read!! https://t.co/uwke0zG6yH
RT @Genomeducator: Horray!! A broader definition of clinical utility from @ampath. A must read!! https://t.co/uwke0zG6yH
RT @Genomeducator: Horray!! A broader definition of clinical utility from @ampath. A must read!! https://t.co/uwke0zG6yH
Horray!! A broader definition of clinical utility from @ampath. A must read!! https://t.co/uwke0zG6yH
RT @Genomeducator: The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer https:/…
The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer https://t.co/ZsNfAN128q
RT @DXWorldNews: Schulzbank recommends AMP paper on clinical utility and validity: https://t.co/q4oQNZa9th #NGDx16
RT @DXWorldNews: Schulzbank recommends AMP paper on clinical utility and validity: https://t.co/q4oQNZa9th #NGDx16
RT @DXWorldNews: Schulzbank recommends AMP paper on clinical utility and validity: https://t.co/q4oQNZa9th #NGDx16
RT @DXWorldNews: Schulzbank recommends AMP paper on clinical utility and validity: https://t.co/q4oQNZa9th #NGDx16
Schulzbank recommends AMP paper on clinical utility and validity: https://t.co/q4oQNZa9th #NGDx16
How to determine clinical utility of precision medicine testing? https://t.co/oz1eAhEJaP https://t.co/jI0249TKCG #vincisupports #vagenomics
RT @DaleYuzuki: Fernandes: Shows new AMP paper Joseph et al https://t.co/40m55X61XB defining clinical utility for inh disease and cancer #…
Fernandes: Shows new AMP paper Joseph et al https://t.co/40m55X61XB defining clinical utility for inh disease and cancer #NGDx16
RT @AMPath: “We need to capture evidence for the #clinicalutility of #molpath outside of a traditional #RCT setting”. @JMDiagn https://t.co…
“We need to capture evidence for the #clinicalutility of #molpath outside of a traditional #RCT setting”. @JMDiagn https://t.co/RZESt2Vlk1
The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer https://t.co/EEwhsx57lm
@AMPath publishes paper expanding the definition of clinical utility for Molecular Diagnostics https://t.co/kkwXzadCpf